======= LMCD1 =======
== Gene Information ==
* **Official Symbol**: LMCD1
* **Official Name**: LIM and cysteine rich domains 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29995|29995]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NZU5|Q9NZU5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LMCD1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LMCD1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604859|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Transcriptional cofactor that restricts GATA6 function by inhibiting DNA-binding, resulting in repression of GATA6 transcriptional activation of downstream target genes. Represses GATA6-mediated trans activation of lung- and cardiac tissue- specific promoters. Inhibits DNA-binding by GATA4 and GATA1 to the cTNC promoter (By similarity). Plays a critical role in the development of cardiac hypertrophy via activation of calcineurin/nuclear factor of activated T-cells signaling pathway. {ECO:0000250, ECO:0000269|PubMed:20026769}.
|LIM|
|PET|
|positive regulation of calcineurin-NFAT signaling cascade|
|positive regulation of calcineurin-mediated signaling|
|regulation of calcineurin-NFAT signaling cascade|
|regulation of calcineurin-mediated signaling|
|positive regulation of calcium-mediated signaling|
|regulation of cardiac muscle hypertrophy|
|regulation of muscle hypertrophy|
|regulation of muscle adaptation|
|regulation of calcium-mediated signaling|
|regulation of muscle system process|
|transcription corepressor activity|
|regulation of system process|
|zinc ion binding|
|negative regulation of transcription by RNA polymerase II|
|positive regulation of intracellular signal transduction|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|positive regulation of signal transduction|
|negative regulation of gene expression|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp465|Cannabidiol 13μM R08 exp465]]|1.87|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.427|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9785
* **Expression level (log2 read counts)**: 1.49
{{:chemogenomics:nalm6 dist.png?nolink |}}